Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,340 active trials259 approved drugs3,859 evidence items
- NCIt
- C7062
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,701 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04900558 | Robotic Radical Cystectomy Outcomes | recruiting | — | 500 | University of FlorenceOTHER | 1 | May 25, 2021 | clinicaltrials |
| NCT03791034 | Cell Free DNA for the Diagnosis and Treatment in Early NSCLC | recruiting | — | 700 | Samsung Medical CenterOTHER | 1 | May 11, 2021 | clinicaltrials |
| A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer |
| recruiting |
| N/A |
| 950 |
| Tianjin Medical University Cancer Institute and HospitalOTHER |
| 1 |
| May 10, 2021 |
| clinicaltrials |
| NCT04878666 | Prospective Assessment of Quality of Life in Patients With Locally Recurrent Breast Cancer and Hyperthermic Radiotherapy(UKT HT03_1) | recruiting | — | 20 | University Hospital TuebingenOTHER | 1 | May 7, 2021 | clinicaltrials |
| NCT03961776 | Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems(DWI_RECT_MRGRT) | recruiting | — | 39 | Institut Paoli-CalmettesOTHER | 2 | May 6, 2021 | clinicaltrials |
| NCT04834544 | A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care | recruiting | Phase 2 | 75 | Peking University Third HospitalOTHER | 1 | May 3, 2021 | clinicaltrials |
| NCT04829708 | Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy | recruiting | Phase 3 | 534 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 29, 2021 | clinicaltrials |
| NCT04019678 | Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.(NEONOD2) | recruiting | N/A | 850 | Istituto Clinico HumanitasOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT04126876 | A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma(INTRIM) | recruiting | Phase 2 | 214 | A.J.M. van den EertweghOTHER | 1 | Apr 15, 2021 | clinicaltrials |
| NCT03541928 | Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery | recruiting | Phase 2 | 60 | The Methodist Hospital Research InstituteOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT04824950 | Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)(CAMIL) | recruiting | N/A | 87 | Centre Henri BecquerelOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04804878 | Morehouse Total Cancer Care Protocol(MSMTCC) | recruiting | — | 5,000 | Morehouse School of MedicineOTHER | 1 | Mar 18, 2021 | clinicaltrials |
| NCT04799002 | Topotecan and Melphalan for Retinoblastoma | recruiting | Phase 3 | 50 | Sun Yat-sen UniversityOTHER | 1 | Mar 16, 2021 | clinicaltrials |
| NCT04669873 | Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast-conserving Surgery(LAPIDARY) | recruiting | N/A | 36 | Instituto Brasileiro de Controle do CancerOTHER | 1 | Mar 8, 2021 | clinicaltrials |
| NCT04778956 | Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma | recruiting | Phase 3 | 218 | Sun Yat-sen UniversityOTHER | 1 | Mar 4, 2021 | clinicaltrials |
| NCT04782557 | EUS Guided HVA and PVA for Circulating Tumor DNA in Patients | recruiting | N/A | 60 | Chinese University of Hong KongOTHER | 1 | Mar 4, 2021 | clinicaltrials |
| NCT04777942 | Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA) | recruiting | N/A | 320 | Sun Yat-sen UniversityOTHER | 1 | Mar 2, 2021 | clinicaltrials |
| NCT04771507 | A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)(IbruOnOff) | recruiting | Phase 1 / Phase 2 | 50 | Jeanette LundinOTHER | 2 | Feb 25, 2021 | clinicaltrials |
| NCT03025477 | Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer(CHIMOVIP) | recruiting | Phase 2 | 84 | Groupe Hospitalier Diaconesses Croix Saint-SimonOTHER | 1 | Feb 11, 2021 | clinicaltrials |
| NCT04215211 | MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence | recruiting | — | 2,500 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT04215224 | Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence | recruiting | — | 3,500 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT04217018 | MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence | recruiting | — | 3,000 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT04217044 | Histopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence | recruiting | — | 3,000 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT04733820 | Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery | recruiting | Phase 3 | 340 | Huazhong University of Science and TechnologyOTHER | 1 | Feb 2, 2021 | clinicaltrials |
| NCT03920033 | Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy(SHARE) | recruiting | N/A | 288 | Asan Medical CenterOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT04483076 | Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer(RESONANCE-II) | recruiting | Phase 3 | 524 | Chinese PLA General HospitalOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT04714957 | PITCHER (Peritoneal Carcinomatosis Heterogeneity) | recruiting | — | 20 | Hospices Civils de LyonOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT04045691 | Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment(BERING) | recruiting | — | 750 | Pierre Fabre Pharma GmbHINDUSTRY | 3 | Jan 19, 2021 | clinicaltrials |
| NCT04675918 | Pediatric In-Hospital Cardiac Arrest International Registry (PACHIN)(PACHIN) | recruiting | — | 500 | Jimena del CastilloOTHER | 1 | Jan 19, 2021 | clinicaltrials |
| NCT04710797 | Lymphadenectomy in Early Ovarian Cancer(LOVE) | recruiting | N/A | 656 | Sun Yat-sen UniversityOTHER | 1 | Jan 15, 2021 | clinicaltrials |
| NCT04702321 | Genetic Risks for Childhood Cancer Complications in Switzerland(GECCOS) | recruiting | — | 6,000 | University Hospital, GenevaOTHER | 1 | Jan 13, 2021 | clinicaltrials |
| NCT04227015 | A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy | recruiting | Early Phase 1 | 72 | He HuangOTHER | 1 | Dec 28, 2020 | clinicaltrials |
| NCT04665882 | Nomogram to Predict Breast Cancer Related Lymphedema | recruiting | N/A | 600 | Wuhan UniversityOTHER | 1 | Dec 16, 2020 | clinicaltrials |
| NCT04666103 | Function Integrity of Neck Anatomy in Thyroid Surgery | recruiting | N/A | 1,264 | Wuhan UniversityOTHER | 1 | Dec 14, 2020 | clinicaltrials |
| NCT03356054 | Phase I-II Study in CD30 Positive Diffuse Large B-cell Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse(HOVON 136 NHL) | recruiting | Phase 1 / Phase 2 | 37 | Stichting Hemato-Oncologie voor Volwassenen NederlandOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT04440436 | Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients | recruiting | Phase 1 / Phase 2 | 52 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | Dec 8, 2020 | clinicaltrials |
| NCT04646759 | Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer | recruiting | Phase 3 | 516 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT04595929 | Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt-(GASPACCO) | recruiting | N/A | 304 | St. Petersburg State Pavlov Medical UniversityOTHER | 1 | Nov 25, 2020 | clinicaltrials |
| NCT03692429 | alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells(alloSHRINK) | recruiting | Phase 1 | 49 | Celyad Oncology SAINDUSTRY | 2 | Nov 20, 2020 | clinicaltrials |
| NCT02878434 | Fertility Preservation in Young Women With Cancer | recruiting | — | 2,000 | University Hospital, GasthuisbergOTHER | 2 | Nov 18, 2020 | clinicaltrials |
| NCT03825861 | Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer(FOLFIRINOX) | recruiting | Phase 2 | 27 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Nov 10, 2020 | clinicaltrials |
| NCT04603872 | CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies | recruiting | Early Phase 1 | 120 | Zhejiang UniversityOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT04532203 | A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies | recruiting | Early Phase 1 | 72 | Zhejiang UniversityOTHER | 1 | Oct 26, 2020 | clinicaltrials |
| NCT04532281 | A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies | recruiting | Early Phase 1 | 120 | Zhejiang UniversityOTHER | 1 | Oct 26, 2020 | clinicaltrials |
| NCT01704716 | High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN) | recruiting | Phase 3 | 3,300 | St. Anna KinderkrebsforschungOTHER | 20 | Oct 23, 2020 | clinicaltrials |
| NCT03591276 | Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer(KEYDOX) | recruiting | Phase 1 / Phase 2 | 15 | Shaare Zedek Medical CenterOTHER | 1 | Oct 23, 2020 | clinicaltrials |
| NCT03315546 | Radiotherapy Delivery in Deep Inspiration for Pediatric Patients(TEDDI) | recruiting | Phase 1 / Phase 2 | 25 | Rigshospitalet, DenmarkOTHER | 2 | Oct 9, 2020 | clinicaltrials |
| NCT04448522 | Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma | recruiting | Phase 3 | 508 | Sun Yat-sen UniversityOTHER | 2 | Sep 28, 2020 | clinicaltrials |
| NCT04453813 | Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma | recruiting | Phase 3 | 226 | Sun Yat-sen UniversityOTHER | 1 | Sep 28, 2020 | clinicaltrials |
| NCT04453826 | Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma | recruiting | Phase 3 | 388 | Sun Yat-sen UniversityOTHER | 1 | Sep 28, 2020 | clinicaltrials |
Data updated 22 days agoSource updated May 25, 2021source: clinicaltrials